Temporal IgG Subtype Changes in Recurrent Idiopathic Membranous Nephropathy

A. G. Kattah, Mariam P Alexander, A. Angioi, A. S. De Vriese, Sanjeev M Sethi, Fernando G Cosio, E. C. Lorenz, L. D. Cornell, Fernando Custodio Fervenza

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Determination of the IgG subtypes within the immune deposits in membranous nephropathy (MN) may be helpful in the differential diagnosis. IgG4 is the predominant subtype in idiopathic MN and recurrent MN, while IgG1, IgG2, and IgG3 subtypes are more common in secondary MN and de novo disease in the allograft. The temporal change of IgG subclasses in individual patients and its correlation with clinical variables have not been studied. We reviewed all posttransplantation protocol and indication biopsies (49) in 18 patients with recurrent MN who underwent transplantation at our center between 1998 and 2013 and performed IgG subtyping (IgG1-4). We tested serum for M-type phospholipase A2 receptor (PLA2R) autoantibodies or performed PLA2R antigen staining on the kidney biopsy. IgG4 was the (co)dominant IgG subtype in 10 of 14 biopsies at the diagnosis of recurrence regardless of PLA2R association. In 8 of 12 transplantations with serial biopsies, the (co)dominant subtype did not change over time. There was a trend toward IgG1 and IgG3 (co)dominance in biopsies >1 year from recurrence and more IgG1 (co)dominant subtyping in the setting of more-advanced EM deposits. Treatment with rituximab did not affect the IgG subtype. In conclusion, the dominant IgG subtype did not change over time in recurrent MN.

Original languageEnglish (US)
JournalAmerican Journal of Transplantation
DOIs
StateAccepted/In press - 2016

Fingerprint

Membranous Glomerulonephritis
Immunoglobulin G
Phospholipase A2 Receptors
Biopsy
Transplantation
Recurrence
Autoantibodies

ASJC Scopus subject areas

  • Transplantation
  • Immunology and Allergy
  • Pharmacology (medical)

Cite this

Temporal IgG Subtype Changes in Recurrent Idiopathic Membranous Nephropathy. / Kattah, A. G.; Alexander, Mariam P; Angioi, A.; De Vriese, A. S.; Sethi, Sanjeev M; Cosio, Fernando G; Lorenz, E. C.; Cornell, L. D.; Fervenza, Fernando Custodio.

In: American Journal of Transplantation, 2016.

Research output: Contribution to journalArticle

@article{db1b1ef5f674437388fd66eeb794b320,
title = "Temporal IgG Subtype Changes in Recurrent Idiopathic Membranous Nephropathy",
abstract = "Determination of the IgG subtypes within the immune deposits in membranous nephropathy (MN) may be helpful in the differential diagnosis. IgG4 is the predominant subtype in idiopathic MN and recurrent MN, while IgG1, IgG2, and IgG3 subtypes are more common in secondary MN and de novo disease in the allograft. The temporal change of IgG subclasses in individual patients and its correlation with clinical variables have not been studied. We reviewed all posttransplantation protocol and indication biopsies (49) in 18 patients with recurrent MN who underwent transplantation at our center between 1998 and 2013 and performed IgG subtyping (IgG1-4). We tested serum for M-type phospholipase A2 receptor (PLA2R) autoantibodies or performed PLA2R antigen staining on the kidney biopsy. IgG4 was the (co)dominant IgG subtype in 10 of 14 biopsies at the diagnosis of recurrence regardless of PLA2R association. In 8 of 12 transplantations with serial biopsies, the (co)dominant subtype did not change over time. There was a trend toward IgG1 and IgG3 (co)dominance in biopsies >1 year from recurrence and more IgG1 (co)dominant subtyping in the setting of more-advanced EM deposits. Treatment with rituximab did not affect the IgG subtype. In conclusion, the dominant IgG subtype did not change over time in recurrent MN.",
author = "Kattah, {A. G.} and Alexander, {Mariam P} and A. Angioi and {De Vriese}, {A. S.} and Sethi, {Sanjeev M} and Cosio, {Fernando G} and Lorenz, {E. C.} and Cornell, {L. D.} and Fervenza, {Fernando Custodio}",
year = "2016",
doi = "10.1111/ajt.13806",
language = "English (US)",
journal = "American Journal of Transplantation",
issn = "1600-6135",
publisher = "Wiley-Blackwell",

}

TY - JOUR

T1 - Temporal IgG Subtype Changes in Recurrent Idiopathic Membranous Nephropathy

AU - Kattah, A. G.

AU - Alexander, Mariam P

AU - Angioi, A.

AU - De Vriese, A. S.

AU - Sethi, Sanjeev M

AU - Cosio, Fernando G

AU - Lorenz, E. C.

AU - Cornell, L. D.

AU - Fervenza, Fernando Custodio

PY - 2016

Y1 - 2016

N2 - Determination of the IgG subtypes within the immune deposits in membranous nephropathy (MN) may be helpful in the differential diagnosis. IgG4 is the predominant subtype in idiopathic MN and recurrent MN, while IgG1, IgG2, and IgG3 subtypes are more common in secondary MN and de novo disease in the allograft. The temporal change of IgG subclasses in individual patients and its correlation with clinical variables have not been studied. We reviewed all posttransplantation protocol and indication biopsies (49) in 18 patients with recurrent MN who underwent transplantation at our center between 1998 and 2013 and performed IgG subtyping (IgG1-4). We tested serum for M-type phospholipase A2 receptor (PLA2R) autoantibodies or performed PLA2R antigen staining on the kidney biopsy. IgG4 was the (co)dominant IgG subtype in 10 of 14 biopsies at the diagnosis of recurrence regardless of PLA2R association. In 8 of 12 transplantations with serial biopsies, the (co)dominant subtype did not change over time. There was a trend toward IgG1 and IgG3 (co)dominance in biopsies >1 year from recurrence and more IgG1 (co)dominant subtyping in the setting of more-advanced EM deposits. Treatment with rituximab did not affect the IgG subtype. In conclusion, the dominant IgG subtype did not change over time in recurrent MN.

AB - Determination of the IgG subtypes within the immune deposits in membranous nephropathy (MN) may be helpful in the differential diagnosis. IgG4 is the predominant subtype in idiopathic MN and recurrent MN, while IgG1, IgG2, and IgG3 subtypes are more common in secondary MN and de novo disease in the allograft. The temporal change of IgG subclasses in individual patients and its correlation with clinical variables have not been studied. We reviewed all posttransplantation protocol and indication biopsies (49) in 18 patients with recurrent MN who underwent transplantation at our center between 1998 and 2013 and performed IgG subtyping (IgG1-4). We tested serum for M-type phospholipase A2 receptor (PLA2R) autoantibodies or performed PLA2R antigen staining on the kidney biopsy. IgG4 was the (co)dominant IgG subtype in 10 of 14 biopsies at the diagnosis of recurrence regardless of PLA2R association. In 8 of 12 transplantations with serial biopsies, the (co)dominant subtype did not change over time. There was a trend toward IgG1 and IgG3 (co)dominance in biopsies >1 year from recurrence and more IgG1 (co)dominant subtyping in the setting of more-advanced EM deposits. Treatment with rituximab did not affect the IgG subtype. In conclusion, the dominant IgG subtype did not change over time in recurrent MN.

UR - http://www.scopus.com/inward/record.url?scp=84965095654&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84965095654&partnerID=8YFLogxK

U2 - 10.1111/ajt.13806

DO - 10.1111/ajt.13806

M3 - Article

C2 - 27017874

AN - SCOPUS:84988672504

JO - American Journal of Transplantation

JF - American Journal of Transplantation

SN - 1600-6135

ER -